|
|
||||||||||
|
J Am Coll Cardiol, 1992; 19:989-997 © 1992 by the American College of Cardiology Foundation |
Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, Saint Louis, Missouri 63110.
This study was performed to define the importance of maintenance of oxidative metabolism as a descriptor and determinant of the potential for functional recovery after revascularization in patients with recent myocardial infarction. In 11 patients (mean interval after infarction 6 days; 5 patients given thrombolytic therapy), positron emission tomography (PET) was performed to characterize myocardial perfusion (with oxygen-15-labeled water), glucose utilization (with fluorine-18-fluorodeoxyglucose) and oxidative metabolism (with carbon-11-acetate). Dysfunctional but viable myocardium was differentiated from nonviable myocardium by assessments of regional function before and after coronary revascularization. The impact of coronary revascularization on regional myocardial perfusion and metabolism was assessed in nine patients in whom tomography was repeated after revascularization. Before revascularization, dysfunctional but viable myocardium (19 segments) and nonviable myocardium (10 segments) exhibited relative perfusion equivalent to 74% and 63% of that of normal myocardium (33 segments), respectively (p less than 0.02). Dysfunctional but viable myocardium exhibited oxidative metabolism equivalent to 74% of that of normal myocardium (p less than 0.02). In contrast, in nonviable myocardium, oxidative metabolism was only 45% of that seen in normal (p less than 0.02) and 60% of that in reversibly dysfunctional myocardium (p less than 0.003). Regional glucose utilization (normalized to regional perfusion) in dysfunctional but viable myocardium was higher than that in normal myocardium (p less than 0.02). Nonviable myocardium exhibited lower levels of glucose utilization than did normal tissue (p less than 0.02). However, in both reversibly and persistently dysfunctional myocardium utilization of glucose normalized to relative perfusion was markedly variable.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
M. A. Stankewicz, C. S. Mansour, R. L. Eisner, K. B. Churchwell, B. R. Williams, S. R. Sigman, J. Streeter, and R. E. Patterson Myocardial Viability Assessment by PET: 82Rb Defect Washout Does Not Predict the Results of Metabolic-Perfusion Mismatch J. Nucl. Med., October 1, 2005; 46(10): 1602 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Camici and D. P. Dutka Repetitive stunning, hibernation, and heart failure: contribution of PET to establishing a link Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H929 - H936. [Full Text] [PDF] |
||||
![]() |
A. F. Maes, F. Van de Werf, L. V. Mesotten, P. B. Flamen, R. S. Kuzo, J. L. Nuyts, and L. Mortelmans Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate J. Am. Coll. Cardiol., January 1, 2001; 37(1): 30 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sato, T. Iwasaki, T. Toyama, Y. Kaneko, T. Inoue, K. Endo, and R. Nagai Prediction of Functional Recovery After Revascularization in Coronary Artery Disease Using 18F-FDG and 123I-BMIPP SPECT* Chest, January 1, 2000; 117(1): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bogaert, A. Maes, F. Van de Werf, H. Bosmans, M.-C. Herregods, J. Nuyts, W. Desmet, L. Mortelmans, G. Marchal, and F. E. Rademakers Functional Recovery of Subepicardial Myocardial Tissue in Transmural Myocardial Infarction After Successful Reperfusion : An Important Contribution to the Improvement of Regional and Global Left Ventricular Function Circulation, January 12, 1999; 99(1): 36 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mobilia, P. Zanco, A. Desideri, G. Neri, F. Alitto, G. Suzzi, F. Chierichetti, L. Celegon, G. Ferlin, and R. Buchberger T wave normalization in infarct-related electrocardiographic leads during exercise testing for detection of residual viability: comparison with positron emission tomography J. Am. Coll. Cardiol., July 1, 1998; 32(1): 75 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz, C. Kappeler, H. Coenen, A. Bockisch, and G. Heusch Positron Emission Tomography Analysis of [1-11C]Acetate Kinetics in Short-term Hibernating Myocardium Circulation, March 17, 1998; 97(10): 1009 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Wolpers, W. Burchert, J. van den Hoff, R. Weinhardt, G.-J. Meyer, and P. R. Lichtlen Assessment of Myocardial Viability by Use of 11C-Acetate and Positron Emission Tomography : Threshold Criteria of Reversible Dysfunction Circulation, March 18, 1997; 95(6): 1417 - 1424. [Abstract] [Full Text] |
||||
![]() |
C. Depre, J.-L. J. Vanoverschelde, B. Gerber, M. Borgers, J. A. Melin, and R. Dion CORRELATION OF FUNCTIONAL RECOVERY WITH MYOCARDIAL BLOOD FLOW, GLUCOSE UPTAKE, AND MORPHOLOGIC FEATURES IN PATIENTS WITH CHRONIC LEFT VENTRICULAR ISCHEMIC DYSFUNCTION UNDERGOING CORONARY ARTERY BYPASS GRAFTING J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 371 - 378. [Abstract] [Full Text] |
||||
![]() |
T. Hata, R. Nohara, M. Fujita, R. Hosokawa, L. Lee, T. Kudo, E. Tadamura, N. Tamaki, J. Konishi, and S. Sasayama Noninvasive Assessment of Myocardial Viability by Positron Emission Tomography With 11C Acetate in Patients With Old Myocardial Infarction: Usefulness of Low-Dose Dobutamine Infusion Circulation, October 15, 1996; 94(8): 1834 - 1841. [Abstract] [Full Text] |
||||
![]() |
Y. Yamamoto, R. de Silva, C. G. Rhodes, H. Iida, A. A. Lammertsma, T. Jones, and A. Maseri Noninvasive Quantification of Regional Myocardial Metabolic Rate of Oxygen by 15O2 Inhalation and Positron Emission Tomography: Experimental Validation Circulation, August 15, 1996; 94(4): 808 - 816. [Abstract] [Full Text] |
||||
![]() |
J. vom Dahl, O. Muzik, E. R. Wolfe Jr, C. Allman, G. Hutchins, and M. Schwaiger Myocardial Rubidium-82 Tissue Kinetics Assessed by Dynamic Positron Emission Tomography as a Marker of Myocardial Cell Membrane Integrity and Viability Circulation, January 15, 1996; 93(2): 238 - 245. [Abstract] [Full Text] |
||||
![]() |
P. Perrone-Filardi, L. Pace, M. Prastaro, F. Piscione, S. Betocchi, F. Squame, P. Vezzuto, A. Soricelli, C. Indolfi, M. Salvatore, et al. Dobutamine Echocardiography Predicts Improvement of Hypoperfused Dysfunctional Myocardium After Revascularization in Patients With Coronary Artery Disease Circulation, May 15, 1995; 91(10): 2556 - 2565. [Abstract] [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |